← Open Payments lookup

JOAN CARAPUCCI: Open Payments

NPI 1255342069 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,783 in 91 payments from 15 companies in 2025. Trend: 2023 $636 · 2024 $1,029 · 2025 $1,783

Food & beverage: $1,783
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.29$440
E.R. Squibb & Sons, L.L.C.16$262
Alkermes, Inc.10$252
Neurocrine BioSciences, Inc.8$186
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$168
Vanda Pharmaceuticals Inc.5$151
Janssen Pharmaceuticals, Inc3$69
Teva Pharmaceuticals USA, Inc.2$56
ACADIA Pharmaceuticals Inc2$38
Janssen Scientific Affairs, LLC1$32

Products named: REXULTI, COBENFY, ARISTADA, INGREZZA, CAPLYTA, FANAPT, ABILIFY ASIMTUFII, SPRAVATO.

Industry payments across NV — which companies pay providers there.